Company profile: Organ-i
1.1 - Company Overview
Company description
- Provider of novel biotech diagnostic tests for renal diseases, improving cliniciansβ ability to monitor the health of transplanted kidneys and providing valuable treatment information for patients.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Organ-i
Cellular Research
HQ: United States
Website
- Description: Provider of biotechnology R&D and highly sensitive life science technologies, including molecular diagnostics (EasyNAT system and diagnostic kits for pathogens such as SARS-CoV-2, flu, RSV, M. tuberculosis, Mycoplasma pneumoniae), digital PCR for COVID-19 detection and monitoring, cell signalling research services with human cell lines, cell culture media (AffiMEDIUM), and antibodies and antigens (Orbigen).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cellular Research company profile β
Tune Therapeutics
HQ: United States
Website
- Description: Provider of an epigenetic programming platform for disease treatment, offering TEMPO to control gene activity without altering DNA sequence by activating, silencing, or fine-tuning gene output, and TUNE-401, an investigational HBV therapy that epigenetically silences viral DNA in host chromosomes and cccDNA to pursue a functional cure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Tune Therapeutics company profile β
Mirati Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology, based at 9363 Towne Centre Dr, San Diego, CA, United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Mirati Therapeutics company profile β
Rewrite Therapeutics
HQ: United States
Website
- Description: Provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Rewrite Therapeutics company profile β
Axenis
HQ: France
Website
- Description: Provider of humanized mouse models as preclinical tools in immunology for the pharmaceutical industry, biotechnology companies, and academic research, using new immunocompromised mouse strains permissive to human tissue xenograft transplantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Axenis company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Organ-i
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Organ-i
2.2 - Growth funds investing in similar companies to Organ-i
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Organ-i
4.2 - Public trading comparable groups for Organ-i
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β